⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

Official Title: Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

Study ID: NCT06360627

Interventions

Computed Tomography

Study Description

Brief Summary: Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University Hospital Zurich - Diagnostic Radiology, Zurich, , Switzerland

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: